{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:57:59Z","timestamp":1791892679443,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jvs.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:00:06Z","timestamp":1791889206000},"page":"1344-1345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letter regarding \u201cHeparin, ACT, and peripheral bypass\u201d"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5483-7826","authenticated-orcid":false,"given":"Thomas A.H.","family":"Steunenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno M.","family":"Wiersema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0129-1607","authenticated-orcid":false,"given":"Vincent","family":"Jongkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2026.07.009_bib1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jvs.2026.05.014","article-title":"Characterizing the association of heparin dose and activated clotting time on lower extremity bypass outcomes","volume":"84","author":"Brown","year":"2026","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.07.009_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvsvf.2025.01.005","article-title":"Strategies for antithrombotic management during non-cardiac arterial procedures: results of the International ACTION Survey","volume":"64","author":"Hoebink","year":"2025","journal-title":"EJVES Vasc Forum"},{"key":"10.1016\/j.jvs.2026.07.009_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejvs.2025.07.027","article-title":"Editor's choice\u2014activated clotting time guided heparinisation during open abdominal aortic aneurysm repair (ACTION-1): a randomised, multicentre, single blind, superiority trial","volume":"70","author":"Jongkind","year":"2025","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2026.07.009_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.avsg.2025.07.041","article-title":"Validation of the E-CABG bleeding severity classification in open peripheral arterial surgery","volume":"122","author":"Steunenberg","year":"2025","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2026.07.009_bib5","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1053\/j.jvca.2020.06.027","article-title":"Evaluation of point-of-care ACT coagulometers and anti-Xa activity during cardiopulmonary bypass","volume":"34","author":"Falter","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jvs.2026.07.009_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.avsg.2024.10.003","article-title":"Ability of activated clotting time measurements to monitor unfractionated heparin activity during non-cardiac arterial procedures","volume":"110","author":"Hoebink","year":"2025","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2026.07.009_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ejvs.2020.08.047","article-title":"Editor's choice\u2014protamine reduces serious bleeding complications associated with carotid endarterectomy in asymptomatic patients without increasing the risk of stroke, myocardial infarction, or death in a large national analysis","volume":"60","author":"Stone","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2026.07.009_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.avsg.2023.10.019","article-title":"The utilization of protamine during peripheral vascular interventions in the VQI","volume":"101","author":"Ali","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2026.07.009_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/ALN.0000000000003903","article-title":"Anticoagulation monitoring for perioperative physicians","volume":"135","author":"Maier","year":"2021","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jvs.2026.07.009_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejvs.2026.01.009","article-title":"Quality of life, cost effectiveness, and cost utility analysis of activated clotting time guided heparinisation vs. a single bolus of heparin in open abdominal aortic aneurysm repair","volume":"72","author":"Steunenberg","year":"2026","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426014412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426014412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:01:33Z","timestamp":1791889293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521426014412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0741521426014412"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2026.07.009","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter regarding \u201cHeparin, ACT, and peripheral bypass\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2026.07.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Vascular Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}